Sunday, February 07, 2016 12:23:32 PM
"Green Cures continues to achieve substantive progress as we work diligently to implement and execute our plans to create and capture shareholder value. We did this first by restructuring the share structure with a 130/1 reverse split. This action was important as it allowed the company to rid itself of the negative reviews, and correct the authorized and outstanding shares on the market. Another benefit is that it has allowed Green Cures to have the opportunity to obtain constructive building capital for the company’s best financial interest while continuing to develop. Further, this has increased share price, ultimately generating greater shareholder returns."
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM